# Andrea Cipriani

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/andrea-cipriani/

## Facts

| Field | Value |
| --- | --- |
| Citations | 46,159 |
| Field | Treatment of Major Depression |
| h-index | 97 |
| i10-index | 345 |
| Last Known Institution | Oxford Health NHS Foundation Trust |
| OpenAlex ID | https://openalex.org/A5007077090 |
| ORCID iD | https://orcid.org/0000-0001-5179-8321 |
| Works | 775 |

## Researcher papers

- [Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis](https://scholariq.org/papers/comparative-efficacy-and-tolerability-of-15-antipsychotic-drugs-in-schizophrenia/)
- [Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis](https://scholariq.org/papers/comparative-efficacy-and-acceptability-of-12-new-generation-antidepressants-a/)
- [Imputing missing standard deviations in meta-analyses can provide accurate results](https://scholariq.org/papers/imputing-missing-standard-deviations-in-meta-analyses-can-provide-accurate/)
- [Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis](https://scholariq.org/papers/comparative-efficacy-and-tolerability-of-medications-for-attention-deficit/)
- [Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology](https://scholariq.org/papers/evidence-based-guidelines-for-treating-bipolar-disorder-revised-third-edition/)
- [Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis](https://scholariq.org/papers/comparative-efficacy-and-acceptability-of-antimanic-drugs-in-acute-mania-a/)
- [Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials](https://scholariq.org/papers/dose-equivalents-of-antidepressants-evidence-based-recommendations-from/)
- [Citalopram versus other anti-depressive agents for depression](https://scholariq.org/papers/citalopram-versus-other-anti-depressive-agents-for-depression/)
- [Dismantling, optimising, and personalising internet cognitive behavioural therapy for depression: a systematic review and component network meta-analysis using individual participant data](https://scholariq.org/papers/dismantling-optimising-and-personalising-internet-cognitive-behavioural-therapy/)
- [Fluoxetine versus other types of pharmacotherapy for depression](https://scholariq.org/papers/fluoxetine-versus-other-types-of-pharmacotherapy-for-depression/)

## Researcher topics

- [Treatment of Major Depression](https://scholariq.org/topics/treatment-of-major-depression-2/)
- [Schizophrenia research and treatment](https://scholariq.org/topics/schizophrenia-research-and-treatment/)
- [Meta-analysis and systematic reviews](https://scholariq.org/topics/meta-analysis-and-systematic-reviews/)
- [Bipolar Disorder and Treatment](https://scholariq.org/topics/bipolar-disorder-and-treatment/)
- [Mental Health Research Topics](https://scholariq.org/topics/mental-health-research-topics/)

## Researcher university

- [Oxford Health NHS Foundation Trust](https://scholariq.org/institutions/oxford-health-nhs-foundation-trust/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.